Article Details

AstraZeneca's COVID-19 vaccine: benefits and risks in context | European Medicines Agency

Retrieved on: 2021-04-23 16:30:39

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's COVID-19 vaccine: benefits and risks in context | European Medicines Agency. View article details on HISWAI: https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-benefits-risks-context

Excerpt

Vaxzevria (formerly COVID-19 Vaccine AstraZeneca) is authorised in the EU to prevent COVID-19, which can cause severe disease and death.

Article found on: www.ema.europa.eu

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up